This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of active pharmaceutical ingredients (APIs). It serves as a key intermediate in the production of drugs targeting neurological disorders, including Parkinson’s disease and other neurodegenerative conditions. Its structural features make it valuable for designing molecules that interact with specific receptors in the brain, such as dopamine receptors, to modulate their activity. Additionally, it is employed in the development of potential therapies for psychiatric disorders, where precise receptor targeting is critical. Its application extends to preclinical studies, where it is used to evaluate efficacy, safety, and pharmacokinetic properties of novel drug candidates.